Market Access News | pharmaphorum

News

NICE backs use of Gilead/Kite CAR-T via Cancer Drugs Fund

A pair of new guidance documents from UK cost-effectiveness authority NICE could see hundreds of more blood cancer patients eligible for treatment with CAR-T therapies fro

News

GSK’s RSV vaccine in EU pole position after CHMP backing

GSK looks set to bring the first vaccine for respiratory syncytial virus (RSV) to market in the EU, after its Arexvy shot was recommended for approval by the EMA’s human m

News

Single market at heart of EU plans for pharma reform

The European Commission’s long-promised revamp of pharmaceutical legislation is finally unveiled, and it’s ambitious to say the least.

News

Biogen gets FDA approval for ALS drug Qalsody

After much deliberation, the FDA has granted accelerated approval for Biogen’s tofersen for an ultra-rare form of the neurodegenerative disease amyotrophic lateral scleros

News

EMA starts review of GSK’s Jemperli in endometrial cancer

GSK has moved a step closer to approval of its cancer immunotherapy Jemperli as a first-line treatment for endometrial cancer in the EU.

News

J&J claims first approval for PARP combo Akeega

Johnson & Johnson has picked up its first regulatory approval worldwide for Akeega, a fixed-dose combination of a PARP inhibitor and anti-androgen therapy, as a treatm

NICE backs use of Gilead/Kite CAR-T via Cancer Drugs Fund

GSK’s RSV vaccine in EU pole position after CHMP backing

Single market at heart of EU plans for pharma reform

Biogen gets FDA approval for ALS drug Qalsody

EMA starts review of GSK’s Jemperli in endometrial cancer

J&J claims first approval for PARP combo Akeega

US judge says Novo Nordisk must face lawsuit over CagriSema

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks